The InWave medical device will be manufactured, marketed and sold through the company’s Zynex Medical subsidiary.
“We are very excited about the introduction of this new product,” said Thomas Sandgaard, CEO of Zynex, in the release. “The InWave adds to our already broad product line and is reimbursed by health insurance. We believe it will provide our expanding sales force an additional tool to fuel revenue generation in our rapid growing Zynex Medical subsidiary.”
Zynex is headquartered in Lone Tree, Colo.
Related Articles on FDA Clearances:
AngioDynamics receives FDA Clearance for Peripherally Inserted Central Catheter
Symmetry Medical Receives FDA Clearance for FLASH PAK Evolution Valve
Covidien Receives FDA Clearance for Stapling System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.